NEPHROS INC (NEPH) Stock Fundamental Analysis
USA - NASDAQ:NEPH - US6406714005 - Common Stock
4.89 USD
-0.44 (-8.26%)
4.9001 USD
+0.01 (+0.21%)
Overall NEPH gets a fundamental rating of 5 out of 10. We evaluated NEPH against 129 industry peers in the Machinery industry. NEPH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. While showing a medium growth rate, NEPH is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
NEPH had positive earnings in the past year.
NEPH had a positive operating cash flow in the past year.
NEPH had negative earnings in 4 of the past 5 years.
NEPH had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
NEPH has a better Return On Assets (10.84%) than 85.27% of its industry peers.
The Return On Equity of NEPH (13.82%) is better than 71.32% of its industry peers.
The Return On Invested Capital of NEPH (10.62%) is better than 75.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.84% | ||
| ROE | 13.82% | ||
| ROIC | 10.62% |
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NEPH's Profit Margin of 7.95% is fine compared to the rest of the industry. NEPH outperforms 63.57% of its industry peers.
With a Operating Margin value of 8.01%, NEPH perfoms like the industry average, outperforming 48.84% of the companies in the same industry.
NEPH has a better Gross Margin (63.37%) than 98.45% of its industry peers.
In the last couple of years the Gross Margin of NEPH has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.01% | ||
| PM (TTM) | 7.95% | ||
| GM | 63.37% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NEPH is creating some value.
NEPH has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, NEPH has more shares outstanding
Compared to 1 year ago, NEPH has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -1.10, we must say that NEPH is in the distress zone and has some risk of bankruptcy.
NEPH has a Altman-Z score of -1.10. This is amonst the worse of the industry: NEPH underperforms 84.50% of its industry peers.
The Debt to FCF ratio of NEPH is 0.01, which is an excellent value as it means it would take NEPH, only 0.01 years of fcf income to pay off all of its debts.
NEPH's Debt to FCF ratio of 0.01 is amongst the best of the industry. NEPH outperforms 93.80% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NEPH is not too dependend on debt financing.
NEPH has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. NEPH outperforms 86.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Altman-Z | -1.1 |
ROIC/WACC1.12
WACC9.46%
2.3 Liquidity
NEPH has a Current Ratio of 5.41. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.41, NEPH belongs to the top of the industry, outperforming 93.02% of the companies in the same industry.
NEPH has a Quick Ratio of 4.14. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 4.14, NEPH belongs to the top of the industry, outperforming 93.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.41 | ||
| Quick Ratio | 4.14 |
3. Growth
3.1 Past
NEPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 192.31%, which is quite impressive.
Looking at the last year, NEPH shows a very strong growth in Revenue. The Revenue has grown by 21.18%.
NEPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)192.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
Revenue 1Y (TTM)21.18%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.89%
3.2 Future
The Earnings Per Share is expected to grow by 13281452764.99% on average over the next years. This is a very strong growth
NEPH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.15% yearly.
EPS Next Y1322977426536356900%
EPS Next 2Y13281452764.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year24.58%
Revenue Next 2Y17.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 40.75, NEPH can be considered very expensive at the moment.
Based on the Price/Earnings ratio, NEPH is valued a bit more expensive than the industry average as 68.22% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 27.40. NEPH is valued slightly more expensive when compared to this.
With a Price/Forward Earnings ratio of 79.90, NEPH can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NEPH indicates a slightly more expensive valuation: NEPH is more expensive than 69.77% of the companies listed in the same industry.
NEPH is valuated expensively when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.75 | ||
| Fwd PE | 79.9 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NEPH is valued a bit more expensive than 73.64% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NEPH is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 25.96 | ||
| EV/EBITDA | 34.81 |
4.3 Compensation for Growth
NEPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NEPH's earnings are expected to grow with 13281452764.99% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y13281452764.99%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NEPH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
4.89
-0.44 (-8.26%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners45.82%
Inst Owner Change0%
Ins Owners10.73%
Ins Owner Change0%
Market Cap51.83M
Analysts82.5
Price Target5.61 (14.72%)
Short Float %0.18%
Short Ratio0.32
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)629.41%
Min EPS beat(2)178.43%
Max EPS beat(2)1080.39%
EPS beat(4)4
Avg EPS beat(4)438.24%
Min EPS beat(4)178.43%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)205.3%
EPS beat(12)7
Avg EPS beat(12)116.27%
EPS beat(16)9
Avg EPS beat(16)82.79%
Revenue beat(2)2
Avg Revenue beat(2)24.79%
Min Revenue beat(2)18.66%
Max Revenue beat(2)30.93%
Revenue beat(4)3
Avg Revenue beat(4)13.61%
Min Revenue beat(4)-1.43%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)2.81%
Revenue beat(12)5
Avg Revenue beat(12)1.07%
Revenue beat(16)6
Avg Revenue beat(16)-1.54%
PT rev (1m)0%
PT rev (3m)15.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)125%
EPS NY rev (3m)800%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.75%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.75 | ||
| Fwd PE | 79.9 | ||
| P/S | 3.11 | ||
| P/FCF | 25.96 | ||
| P/OCF | 25.96 | ||
| P/B | 5.4 | ||
| P/tB | 6.23 | ||
| EV/EBITDA | 34.81 |
EPS(TTM)0.12
EY2.45%
EPS(NY)0.06
Fwd EY1.25%
FCF(TTM)0.19
FCFY3.85%
OCF(TTM)0.19
OCFY3.85%
SpS1.57
BVpS0.91
TBVpS0.78
PEG (NY)0
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.84% | ||
| ROE | 13.82% | ||
| ROCE | 12.77% | ||
| ROIC | 10.62% | ||
| ROICexc | 20.6% | ||
| ROICexgc | 27.01% | ||
| OM | 8.01% | ||
| PM (TTM) | 7.95% | ||
| GM | 63.37% | ||
| FCFM | 11.97% |
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score7
Asset Turnover1.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.01 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 0% | ||
| Cap/Sales | 0% | ||
| Interest Coverage | 668.5 | ||
| Cash Conversion | 135.12% | ||
| Profit Quality | 150.49% | ||
| Current Ratio | 5.41 | ||
| Quick Ratio | 4.14 | ||
| Altman-Z | -1.1 |
F-Score7
WACC9.46%
ROIC/WACC1.12
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)192.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%166.67%
EPS Next Y1322977426536356900%
EPS Next 2Y13281452764.99%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)21.18%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%35.89%
Revenue Next Year24.58%
Revenue Next 2Y17.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y197.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1326.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1326.43%
OCF growth 3YN/A
OCF growth 5YN/A